Allergan Physician Production Information. Botox cosmetic (botulinum toxin type A). Published April 2008.
FDA approves Botox to treat chronic migraines. US Food & Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229782.htm. Published October 15, 2010. Accessed February 12, 2014.
Ondo WG, Gollomp S, Galvez-Jimenez N. A pilot study of botulinum toxin A for headache in cervical dystonia.
Ward A, Roberts G, Warner J, et al. Cost-effectiveness of botulinum toxin type A in the treatment of post-stroke spasticity.
J Rehabil Med. 2005;37(4):252-257.
11/4/2009 DynaMed Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: FDA gives update on botulinum toxin safety warnings. US Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm175013.htm. Updated August 3, 2009. Accessed November 4, 2009.
3/19/2010 DynaMed Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: FDA approves Botox to treat spasticity in flexor muscles of the elbow, wrist and fingers. US Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm203776.htm. Updated March 9, 2010. Accessed March 19, 2010.
5/17/2012 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Jackson JL, Kuriyama A, Hayashino Y. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
American Society for Dermatologic Surgery
American Society of Plastic Surgeons
Canadian Dermatology Association